Trial Profile
An open label pharmcokinetic study of a topical formulation of lidocaine (SHACT) for pain relief in women receiving an Intra Uterine Device.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Nov 2015
Price :
$35
*
At a glance
- Drugs Lidocaine (Primary)
- Indications Procedural pain
- Focus Pharmacokinetics
- 04 Aug 2012 Status changed from recruiting to completed as reported by European Clinical Trials Database record.
- 02 May 2012 New trial record
- 30 Apr 2012 First patient dosed, as reported by Pharmanest